1.
The pathogenesis of cardiac fibrosis
by Kong, Ping
Cellular and molecular life sciences : CMLS, 2013-05-07, Vol.71 (4), p.549-574
2.
The Immunology of Fibrosis
by Wick, Georg
Annual review of immunology, 2013-03-21, Vol.31 (1), p.107-135
3.
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
by Wynn, Thomas A
Nature medicine, 2012-07-06, Vol.18 (7), p.1028-1040
4.
Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs
by Henderson, Neil C
Nature medicine, 2013-12, Vol.19 (12), p.1617-1624
5.
Origin and function of myofibroblasts in kidney fibrosis
by LeBleu, Valerie S
Nature medicine, 2013-08, Vol.19 (8), p.1047-1053
6.
Metformin reverses established lung fibrosis in a bleomycin model
by Rangarajan, Sunad
Nature medicine, 2018-08, Vol.24 (8), p.1121-1127
7.
Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury
by Dulauroy, Sophie
Nature Medicine, 2012-08, Vol.18 (8), p.1262-1270
8.
Biology of pancreatic stellate cells—more than just pancreatic cancer
by Ferdek, Pawel E
Pflügers Archiv, 2017-04-05, Vol.469 (9), p.1039-1050
9.
B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease
by Della-Torre, Emanuel
Annals of the rheumatic diseases, 2015-12, Vol.74 (12), p.2236-2243
10.
Stromal cell-derived factor-1 overexpression induces gastric dysplasia through expansion of stromal myofibroblasts and epithelial progenitors
by Shibata, Wataru
Gut, 2013-02, Vol.62 (2), p.192-200
11.
New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis
by Fernandez, Isis E, MD
The Lancet (British edition), 2012, Vol.380 (9842), p.680-688
12.
Anti-fibrotic effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidence
by Sandner, Peter
Respiratory medicine, 2016, Vol.122, p.S1-S9
13.
A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets
by Jia, Dongyu
Cancer letters, 2016, Vol.382 (2), p.203-214
14.
Critical Role of CXCL16 in Hypertensive Kidney Injury and Fibrosis
by YUNFENG XIA
Hypertension (Dallas, Tex. 1979), 2013, Vol.62 (6), p.1129-1137
15.
Hepatocyte Growth Factor Reduces Cardiac Fibrosis by Inhibiting Endothelial-Mesenchymal Transition
by Okayama, Keita
Hypertension (Dallas, Tex. 1979), 2012-05, Vol.59 (5), p.958-965
16.
Anti-fibrogenic strategies and the regression of fibrosis
by Kisseleva, Tatiana, M.D., PhD
Baillière's best practice & research. Clinical gastroenterology, 2011, Vol.25 (2), p.305-317
17.
Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling
by Distler, Alfiya
Annals of the rheumatic diseases, 2013-09, Vol.72 (9), p.1575-1580
18.
A Genome-wide Association Study of Dupuytren Disease Reveals 17 Additional Variants Implicated in Fibrosis
by Ng, Michael
American journal of human genetics, 2017-09-07, Vol.101 (3), p.417-427
19.
Involvement of interleukin-17A-induced expression of heat shock protein 47 in intestinal fibrosis in Crohn's disease
by Honzawa, Yusuke
Gut, 2014-12, Vol.63 (12), p.1902-1912
20.
